Inhibition of actin polymerization prevents cocaine-induced changes in spine morphology in the nucleus accumbens.
Withdrawal from daily cocaine administration causes an increase in actin cycling and increases spine head diameter in medium spiny neurons from the core of the nucleus accumbens. In order to determine if these two effects of cocaine are mechanistically linked, after 3 weeks of withdrawal from 1 week of daily cocaine treatments, we microinjected latrunculin into the accumbens to inhibit actin polymerization and prevent actin cycling. In cocaine-treated animals, latrunculin-reduced dendritic spine density and decreased the levels of F-actin and PSD-95 in postsynaptic density subfractions. In contrast, latrunculin did not affect spine density or protein levels in saline-treated subjects. Cocaine withdrawn animals show an increase in spine head diameter 45 min after an acute injection of cocaine, and latrunculin abolished the ability of acute cocaine to increase spine head diameter and simultaneously inhibited the sensitized behavioral response. In contrast, latrunculin had no effect in control animals on the acute locomotor response to cocaine. Altogether, these data support previous findings that withdrawal from cocaine is associated with increased actin cycling, and that the increase in actin cycling contributes to cocaine-induced changes in spine morphology of medium spiny neurons in the accumbens core.
Toda
Shigenobu
S
Department of Neurosciences, Medical University of South Carolina, 173 Ashley Ave, BSB410, Charleston, SC 29425, USA.
Shen
Haowei
H
Kalivas
Peter W
PW
D000199:Actins / Q000037:antagonists & inhibitors* / Q000378:metabolism; D000818:Animals; D003042:Cocaine / Q000008:administration & dosage*; D049229:Dendritic Spines / Q000187:drug effects / Q000378:metabolism / Q000473:pathology*; D008297:Male; D009714:Nucleus Accumbens / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology*; D055503:Protein Multimerization / Q000187:drug effects*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013375:Substance Withdrawal Syndrome / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control
D000199:Actins; D003042:Cocaine
J Neurosci. 2006 Feb 1;26(5):1579-87
16452681
Neuron. 2003 May 8;38(3):447-60
12741991
Psychopharmacology (Berl). 2003 Jul;168(1-2):3-20
12402102
Brain Struct Funct. 2008 Sep;213(1-2):149-57
18535839
Ann N Y Acad Sci. 1992 Jun 28;654:335-46
1321575
Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12;363(1507):3233-43
18640922
Nat Rev Neurosci. 2009 Aug;10(8):561-72
19571793
Trends Neurosci. 2005 Apr;28(4):182-7
15808352
Nat Neurosci. 2009 Feb;12(2):182-9
19136971
Neuropharmacology. 2004;47 Suppl 1:33-46
15464124
Psychopharmacology (Berl). 2000 Aug;151(2-3):99-120
10972458
Learn Mem. 2009 Apr 20;16(5):279-88
19380710
J Neurosci. 2009 Mar 4;29(9):2876-84
19261883
J Neurosci. 2006 Mar 29;26(13):3584-8
16571766
Annu Rev Neurosci. 2006;29:565-98
16776597
Nature. 2008 Jul 3;454(7200):118-21
18500330
Trends Neurosci. 2003 Jul;26(7):360-8
12850432
Nat Cell Biol. 2000 Jun;2(6):376-8
10854330
Prog Brain Res. 2008;169:199-207
18394475